CFTR and cyst: Three of these compounds, Bosutinib, Vermurafenib and the CFTR inhibitor IOWH-032, which equally reduced the viability of both wt and Pkd1-null cell types (as ΔAUC did not pass the cutoff), reduced cyst formation.